Center for Cancer & Blood Disorders
6410 Rockledge Dr #660
Bethesda, Maryland 20817
(301) 571-0019 http://www.ccbdmd.com

Use our guide to learn which trials are right for you!

Widely recognized for its compassionate, expert care, the Center for Cancer and Blood Disorders treats patients throughout the Washington, D.C. area and around the country. Our physicians are Board-certified oncology and hematology specialists who oversee a staff of highly trained physician assistants, nurse practitioners and nurses. Our facilities and technology are the finest available. Our clinical trials are leading the drive toward new options in cancer treatment.

We understand, both professionally and personally, the experience of being diagnosed with a serious disease.We make every effort to schedule your first visit within 48 hours and have designed our treatment centers in Bethesda, Maryland, and Germantown, Maryland, to integrate the best of medical science into an attractive, healing environment that welcomes family participation.

Finally, we subscribe to a wide range of health insurance plans and offer personalized financial counseling so that financial obstacles do not prevent you from receiving appropriate treatment.

We've found
48 trials
at this facility
Diffuse Large B-Cell Lymphoma Clinical Trial
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling
Updated: 6/27/2012
mi
from
Bethesda, MD
Click here to add this to my saved trials
Glioblastoma Multiforme Clinical Trial
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Status: Enrolling, Phase I, II
Updated: 11/12/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Indolent Non-Hodgkins Lymphomas Clinical Trial
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Status: Enrolling, Phase III
Updated: 3/3/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Efficacy and Safety of Idelalisib (GS-1101; CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 2/21/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Immune Thrombocytopenic Purpura Clinical Trial
Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Lymphoma, Large B-Cell, Diffuse Clinical Trial
Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Status: Enrolling, Phase I
Updated: 3/27/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Extension Study for Patients Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study
Status: Enrolling
Updated: 6/28/2013
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 1/9/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects
Status: Enrolling, Phase I
Updated: 3/3/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Indolent Non-Hodgkins Lymphomas Clinical Trial
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Status: Enrolling, Phase III
Updated: 3/1/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 2/2/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase III
Updated: 3/25/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Master Protocol Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) (CheckMate 370)
Status: Enrolling, Phase I, II
Updated: 3/28/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
Status: Enrolling, Phase III
Updated: 4/28/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Metastatic Pancreatic Adenocarcinoma Clinical Trial
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 1/19/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Small Cell Lung Cancer Clinical Trial
G1T28 (CDK 4/6 Inhibitor) in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)
Status: Enrolling, Phase I, II
Updated: 2/1/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone (EPd) in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide
Status: Enrolling, Phase II
Updated: 3/28/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Metastatic Pancreatic Adenocarcinoma Clinical Trial
Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non-Hodgkin's Lymphoma Clinical Trial
Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients
Status: Enrolling, Phase II
Updated: 6/23/2005
mi
from
Bethesda, MD
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment
Status: Enrolling, Phase II
Updated: 7/7/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Advanced Multiple Myeloma Clinical Trial
A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)
Status: Enrolling, Phase II
Updated: 7/16/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Subjects With Unresectable or Metastatic Melanoma (CheckMate 218)
Status: Enrolling
Updated: 3/17/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Phase 3b/4 Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Renal Cell Carcinoma (CheckMate 374)
Status: Enrolling, Phase IV
Updated: 3/28/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 5/4/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Oprozomib and Dexamethasone, in Combination With Lenalidomide or Oral Cyclophosphamide in Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/31/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW)
Status: Enrolling, Phase III
Updated: 10/9/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 3/28/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Squamous Cell Carcinoma, Non-Small-Cell Lung Clinical Trial
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling, Phase I, II
Updated: 1/4/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Status: Enrolling, Phase II
Updated: 3/14/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
HER2 Negative Breast Cancer Clinical Trial
Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 1/5/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Immune Thrombocytopenic Purpura Clinical Trial
A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Status: Enrolling, Phase III
Updated: 1/29/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
Status: Enrolling, Phase II, III
Updated: 3/30/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non Squamous Non Small Cell Lung Cancer Clinical Trial
Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 3/21/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Status: Enrolling, Phase III
Updated: 1/5/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 1/28/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Lymphoma Clinical Trial
Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
Status: Enrolling, Phase II
Updated: 2/2/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
Status: Enrolling, Phase I, II
Updated: 3/8/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 3/3/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
Status: Enrolling, Phase I, II
Updated: 1/8/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 2/9/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
Status: Enrolling, Phase I
Updated: 2/26/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
Status: Enrolling, Phase II
Updated: 3/14/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials